Wellth combines daily motivation, behavioral economics, and financial incentives to drive measurable behavior change for patients, encouraging actions like medication taking, blood pressure and glucose checks, and preventive visits. Its app delivers social‑media–like daily engagement designed to reach historically hard‑to‑reach Medicare Advantage, Medicaid, and D‑SNP populations. To date members have completed over 50 million daily check‑ins, achieving an average 90% care‑plan adherence, a 51% reduction in inpatient admissions, and a 16% improvement in medication adherence (PDC); the platform has helped partners attain 4+ Star ratings on Medicare Part C and D measures and reduce avoidable costs. Wellth will use new funding to broaden access across high‑need populations, accelerate product innovation and partner growth, and introduce generative AI capabilities to personalize motivation and care journeys. The company emphasizes a decade plus of behavioral data and outcomes as the basis for scaling its Daily Care Motivation approach. Wellth is based in Los Angeles and has been operating for 11 years. Wellth is a digital health company that applies behavioral economics and machine learning to drive daily health behaviors via a mobile app. Users perform simple daily tasks—such as snapping photos of medications or glucose readings—to form habits and increase adherence. The platform reports 91% daily member engagement and outcomes including a 42% average reduction in inpatient utilization, a 29% reduction in ED utilization, and a 16% improvement in medication adherence. Wellth's customers include health plans and provider organizations, and clients have measured cost savings and improved Medicare Advantage Star ratings. Founded in 2014 and headquartered in Los Angeles, the company has achieved impressive annual growth. The new capital will be used to further invest in the behavioral science engine behind the app and to expand the team to support a growing member base. Wellth provides a platform that uses behavioral economics, financial incentives and nudges to improve patient treatment adherence. Members submit scheduled virtual check-ins—typically daily—such as photos of medication or readings from glucometers and blood pressure cuffs. Check-ins are processed immediately by Wellth’s AI technology for verification, and insights can be relayed directly to care teams. Members keep an endowed daily amount and “cash out” at milestone intervals, creating instant gratification and reinforcing healthy habits. Led by CEO and co-founder Matthew Loper, the company plans to use new capital to expand its platform to new use cases. Wellth is based in New York City and recently raised a new funding round to support growth. Wellth is a Brooklyn-based behavioral economics startup that works with insurers and risk-bearing providers to motivate patient behavior change and treatment adherence. Its core product is a mobile patient experience that delivers daily contextual and personalized nudges and quick 'check-ins' for daily medications, using financial incentives and behavioral economics strategies. The company focuses on costly chronic diseases where poor adherence drives preventable hospitalizations and readmissions, including Type 2 Diabetes, Congestive Heart Failure, Cardiovascular Disease, COPD, Asthma and Behavioral Health. Wellth is led by CEO and co-founder Matt Loper. The company recently raised $5.1M in a Series A round to continue expanding its team and platform. It aims to help payers and providers better understand and improve patient behaviors to reduce costs associated with chronic disease management. Wellth is a digital health startup whose app tracks medication adherence, records weight, and uses incentives to motivate healthier lifestyle changes. CEO and co-founder Matt Loper said the company will use new funding to enable full-scale commercial implementations. Wellth has planned launches over the next six months and intends to generate data on interventions in type 2 diabetes, congestive heart failure, and post–heart attack discharge. The company’s near-term goal is to execute those implementations and publish data on impacts to adherence, health outcomes, and healthcare costs. Customers are insurers and risk-bearing providers, particularly in commercial and managed Medicaid markets, and Wellth typically charges on a per-user basis. The company says its actuarial model projects 4x+ returns after accounting for incentive payouts and Wellth fees.

Total raised

$73M

Funding rounds

5

Latest round

Series C

Latest activity

Aug 2025